GQMA
Current Information
Events 2019/2020
As the 3rd european quality conference is scheduled November 6th - 8th, 2019 in Dublin the schedule for GQMA events was adpated in 2019. The annual meeting (including members meeting) was held March 27th, 2019 in Berlin focussing on interesting GLP, GMP and GDP topics.
GCP topics were covered the two following days during the annual congress of the DGPharMed.
3rd European QA Conference 2019
November 6-8th, 2019 in Dublin/Ireland, Dublin Convention Centre
Further information can be found here.
6th Global QA Conference 2020
February 17-20th, 2020 in Sendai/Japan, Sendai International Center
Further information can be found here.
25th Annual GQMA conference 2020
September 17-18th, 2020 in Duesseldorf/Neuss, Dorint Kongresshotel
Further details will be communicated upon availability.
Checklist of the GDP working group on Audits and Inspections
The GQMA GDP working group (founded in 2016), an interesting and heterogeneous group consisting of different braches (service providers and consultants, carrier, authority representatives, logisticians and manufacturer of pharmaceuticals/active ingredients), has developed recently a checklist GDP Audits- and Inspections that can be used as standard during audits and inspections based on the current status of science and technology. The objective was to generate a consistent vocabulary and understanding at distributors and logisticians. It is the first guidance of the working group and available for GQMA members for a free download soon.
The GQMA
The German Quality Management Association (GQMA) is Germany’s largest, and Europe’s second largest, association dedicated to quality management in the chemical and pharmaceutical industries. Why we chose the term "Good Research Practice" you can read at the end of this text.
By our own periodicals, seminar presentations, and annual meetings (usually held in September each year), we try to achieve a high degree of information and advanced training for the members. Our working groups promote an exchange of views, engage in the evaluation of current topics in the relevant spheres of activity, and represent the GQMA point of view in publications. Contacts with other QA societies and organizations serves the cooperation for conferences and in the evaluation of guidelines in the different GxP areas.
Objectives:
- Promotion of the exchange of scientific information and opinion,
- Promotion of specific education and training,
- Resulting close contact with other national national and international organizations with the aim of appropriate participation in national and international committees,
- Maintain contact with law-makers or authorities in the sense of the society,
- Promotion of contacts with national or international professional associations of the same area of interest.
History:
The German Quality Management Association (Deutsche Gesellschaft für Gute Forschungspraxis, DGGF) was founded as a legal entity in 1995 by 14 members (under the overall control of Stephen Harston) of an informal discussion group which had already been in existence for several years.
Today we have more than 900 members - mainly from Germany, but also from Switzerland, Austria, the Netherlands, Spain and the USA.
Members work in Research and Development Departments in industry, contract research organisations, central clinical laboratories, hospitals and government agencies.
Our members are quality assurance professionals, study directors, study physicians, test facility managers, archivists and monitors - all with the same interest in good quality in their areas of expertise.
Good Research Practices:
The term "Good Research Practices" is used to describe a mixture of legal requirements and voluntary measures taken by those involved in research and development studies with chemical products (particularly, but not only, pharmaceutical products and agrochemical products) to ensure that the studies are planned, performed and documented in a reliable and transparent way. This is done so that decisions taken based on the reports of these studies are sound and of high scientific quality. The term thus covers "Good Laboratory Practices, GLP" (which relate to the planning, conduct and reporting of so-called "safety studies" [mainly toxicity studies] with pharmaceuticals, agro-chemicals and various industrial chemicals) and "Good Clinical Practices, GCP" (which relate to clinical studies with new pharmaceutical products).
As the 3rd european quality conference is scheduled November 6th - 8th, 2019 in Dublin the schedule for GQMA events was adpated in 2019. The annual meeting (including members meeting) was held March 27th, 2019 in Berlin focussing on interesting GLP, GMP and GDP topics.
GCP topics were covered the two following days during the annual congress of the DGPharMed.
3rd European QA Conference 2019
November 6-8th, 2019 in Dublin/Ireland, Dublin Convention Centre
Further information can be found here.
6th Global QA Conference 2020
February 17-20th, 2020 in Sendai/Japan, Sendai International Center
Further information can be found here.
25th Annual GQMA conference 2020
September 17-18th, 2020 in Duesseldorf/Neuss, Dorint Kongresshotel
Further details will be communicated upon availability.
Checklist of the GDP working group on Audits and Inspections
The GQMA GDP working group (founded in 2016), an interesting and heterogeneous group consisting of different braches (service providers and consultants, carrier, authority representatives, logisticians and manufacturer of pharmaceuticals/active ingredients), has developed recently a checklist GDP Audits- and Inspections that can be used as standard during audits and inspections based on the current status of science and technology. The objective was to generate a consistent vocabulary and understanding at distributors and logisticians. It is the first guidance of the working group and available for GQMA members for a free download soon.
The GQMA
The German Quality Management Association (GQMA) is Germany’s largest, and Europe’s second largest, association dedicated to quality management in the chemical and pharmaceutical industries. Why we chose the term "Good Research Practice" you can read at the end of this text.
By our own periodicals, seminar presentations, and annual meetings (usually held in September each year), we try to achieve a high degree of information and advanced training for the members. Our working groups promote an exchange of views, engage in the evaluation of current topics in the relevant spheres of activity, and represent the GQMA point of view in publications. Contacts with other QA societies and organizations serves the cooperation for conferences and in the evaluation of guidelines in the different GxP areas.
Objectives:
- Promotion of the exchange of scientific information and opinion,
- Promotion of specific education and training,
- Resulting close contact with other national national and international organizations with the aim of appropriate participation in national and international committees,
- Maintain contact with law-makers or authorities in the sense of the society,
- Promotion of contacts with national or international professional associations of the same area of interest.
History:
The German Quality Management Association (Deutsche Gesellschaft für Gute Forschungspraxis, DGGF) was founded as a legal entity in 1995 by 14 members (under the overall control of Stephen Harston) of an informal discussion group which had already been in existence for several years.
Today we have more than 900 members - mainly from Germany, but also from Switzerland, Austria, the Netherlands, Spain and the USA.
Members work in Research and Development Departments in industry, contract research organisations, central clinical laboratories, hospitals and government agencies.
Our members are quality assurance professionals, study directors, study physicians, test facility managers, archivists and monitors - all with the same interest in good quality in their areas of expertise.
Good Research Practices:
The term "Good Research Practices" is used to describe a mixture of legal requirements and voluntary measures taken by those involved in research and development studies with chemical products (particularly, but not only, pharmaceutical products and agrochemical products) to ensure that the studies are planned, performed and documented in a reliable and transparent way. This is done so that decisions taken based on the reports of these studies are sound and of high scientific quality. The term thus covers "Good Laboratory Practices, GLP" (which relate to the planning, conduct and reporting of so-called "safety studies" [mainly toxicity studies] with pharmaceuticals, agro-chemicals and various industrial chemicals) and "Good Clinical Practices, GCP" (which relate to clinical studies with new pharmaceutical products).
